These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 15830061

  • 21. Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study.
    Rosales RL, Balcaitiene J, Berard H, Maisonobe P, Goh KJ, Kumthornthip W, Mazlan M, Latif LA, Delos Santos MMD, Chotiyarnwong C, Tanvijit P, Nuez O, Kong KH.
    Toxins (Basel); 2018 Jun 21; 10(7):. PubMed ID: 29933562
    [Abstract] [Full Text] [Related]

  • 22. Optimising the methods of evaluation of the effectiveness of botulinum toxin treatment of post-stroke muscle spasticity.
    Bakheit AM.
    J Neurol Neurosurg Psychiatry; 2004 May 21; 75(5):665-6. PubMed ID: 15090554
    [No Abstract] [Full Text] [Related]

  • 23. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase.
    Abo M, Shigematsu T, Hara H, Matsuda Y, Nimura A, Yamashita Y, Takahashi K.
    Toxins (Basel); 2020 Feb 18; 12(2):. PubMed ID: 32085529
    [Abstract] [Full Text] [Related]

  • 24. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD, Vuadens P, van Wijck FM, Stark S, Johnson GR, Barnes MP.
    Clin Rehabil; 2002 Sep 18; 16(6):654-60. PubMed ID: 12392341
    [Abstract] [Full Text] [Related]

  • 25. More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke.
    Demetrios M, Brand C, Louie J, Khan F.
    J Rehabil Med; 2016 Apr 28; 48(5):426-34. PubMed ID: 27097568
    [Abstract] [Full Text] [Related]

  • 26. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.
    Arch Phys Med Rehabil; 2008 May 28; 89(5):799-806. PubMed ID: 18452724
    [Abstract] [Full Text] [Related]

  • 27. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A, Micello MF, Panza F, Fortunato F, Baricich A, Cisari C, Pilotto A, Logroscino G, Fiore P, Ranieri M.
    J Neurol Sci; 2014 Dec 15; 347(1-2):39-43. PubMed ID: 25263601
    [Abstract] [Full Text] [Related]

  • 28. Poststroke Postural Sway Improved by Botulinum Toxin: A Multicenter Randomized Double-blind Controlled Trial.
    Kerzoncuf M, Viton JM, Pellas F, Cotinat M, Calmels P, Milhe de Bovis V, Delarque A, Bensoussan L.
    Arch Phys Med Rehabil; 2020 Feb 15; 101(2):242-248. PubMed ID: 31469982
    [Abstract] [Full Text] [Related]

  • 29. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P, Denis A, Gasq D, Chaleat-Valayer E, Yelnik A, Colin C, Botuloscope Group, Pérennou D.
    Ann Phys Rehabil Med; 2019 Jul 15; 62(4):207-213. PubMed ID: 31229700
    [Abstract] [Full Text] [Related]

  • 30. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C, Botox Post-Stroke Spasticity Study Group.
    N Engl J Med; 2002 Aug 08; 347(6):395-400. PubMed ID: 12167681
    [Abstract] [Full Text] [Related]

  • 31. Effectiveness of botulinum toxin type A on gait and quality of life in adult post-stroke patients with lower limb spasticity: a systematic review protocol.
    Chu WH, Gupta AD.
    JBI Database System Rev Implement Rep; 2016 Jun 08; 14(6):23-9. PubMed ID: 27532646
    [Abstract] [Full Text] [Related]

  • 32. [Pharmacology and upper limb poststroke spasticity: a review. International Society of Prosthetics and Orthotics].
    Yelnik AP.
    Ann Readapt Med Phys; 2004 Oct 08; 47(8):575-89. PubMed ID: 15465163
    [Abstract] [Full Text] [Related]

  • 33. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
    Santamato A, Panza F, Intiso D, Baricich A, Picelli A, Smania N, Fortunato F, Seripa D, Fiore P, Ranieri M.
    J Neurol Sci; 2017 Jul 15; 378():182-186. PubMed ID: 28566161
    [Abstract] [Full Text] [Related]

  • 34. Randomized, placebo-controlled trial of incobotulinumtoxina for upper-limb post-stroke spasticity.
    Elovic EP, Munin MC, Kaňovský P, Hanschmann A, Hiersemenzel R, Marciniak C.
    Muscle Nerve; 2016 Mar 15; 53(3):415-21. PubMed ID: 26201835
    [Abstract] [Full Text] [Related]

  • 35. Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients.
    Albani G, Cimolin V, Galli M, Vimercati S, Bar D, Campanelli L, Gandolfi R, Lombardi R, Mauro A.
    Funct Neurol; 2010 Mar 15; 25(2):103-7. PubMed ID: 20923608
    [Abstract] [Full Text] [Related]

  • 36. Botulinum toxin type A for refractory post-stroke shoulder pain.
    Pedreira G, Cardoso E, Melo A.
    Arq Neuropsiquiatr; 2008 Jun 15; 66(2A):213-5. PubMed ID: 18545785
    [Abstract] [Full Text] [Related]

  • 37. Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke.
    Santamato A, Panza F, Filoni S, Ranieri M, Solfrizzi V, Frisardi V, Dellomonaco A, Amoruso MT, Amoruso L, Kehoe PG, Megna M, Fiore P.
    Brain Inj; 2010 Jun 15; 24(9):1108-12. PubMed ID: 20569045
    [Abstract] [Full Text] [Related]

  • 38. IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study.
    Marciniak C, Munin MC, Brashear A, Rubin BS, Patel AT, Slawek J, Hanschmann A, Hiersemenzel R, Elovic EP.
    Adv Ther; 2019 Jan 15; 36(1):187-199. PubMed ID: 30484117
    [Abstract] [Full Text] [Related]

  • 39. Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke.
    Gordon MF, Brashear A, Elovic E, Kassicieh D, Marciniak C, Liu J, Turkel C, BOTOX Poststroke Spasticity Study Group.
    Neurology; 2004 Nov 23; 63(10):1971-3. PubMed ID: 15557529
    [Abstract] [Full Text] [Related]

  • 40. Botulinum toxin type A in post-stroke upper limb spasticity.
    Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M, GSK1358820 Spasticity Study Group.
    Curr Med Res Opin; 2010 Aug 23; 26(8):1983-92. PubMed ID: 20569068
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.